Literature DB >> 436784

Suppression of vasopressin secretion by clonidine: effect of alpha-adrenoceptor antagonists.

I A Reid, P L Nolan, J A Wolf, L C Keil.   

Abstract

Studies were performed in anesthetized dogs to determine if the diuretic effect of clonidine results from inhibition of vasopressin secretion. Intravenous clonidine (30 microgram/kg) decreased plasma vasopressin concentration (as measured by RIA) from 10.9 +/- 1.5 to 5.0 +/- 1.1 ng/ml (P less than 0.01) in association with a transient increase in arterial blood pressure and a decrease in heart rate. Intravenous administration of two alpha-adrenoceptor antagonists, piperoxane and phentolamine, virtually abolished the pressor effect of clonidine but did not prevent the suppression of plasma vasopressin concentration. Clonidine decreased plasma vasopressin concentration from 11.9 +/- 3.1 to 3.3 +/- 1.0 pg/ml in the phentolamine-treated dogs (P less than 0.01) and from 18.1 +/- 4.5 to 12.4 +/- 3.6 pg/ml in the piperoxane-treated dogs (P less than 0.05). These results provide direct evidence that the diuretic effect of clonidine results from inhibition of the secretion of vasopressin. This inhibition does not appear to be a consequence of the pressor effect of the drug but may result from a direct action in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436784     DOI: 10.1210/endo-104-5-1403

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

1.  Localisation of [3H] clonidine binding in rat neurohypophysis by means of electron-microscopic autoradiography.

Authors:  A Livingston; B Morris
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

2.  Abnormal suppression of arginine-vasopressin by clonidine in multiple system atrophy.

Authors:  J Kimber; L Watson; C J Mathias
Journal:  Clin Auton Res       Date:  1999-10       Impact factor: 4.435

3.  Autoradiographic demonstration of alpha 2 adrenoceptors in the bovine neurohypophysis.

Authors:  B Morris; A Livingston
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

4.  Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.

Authors:  V J Nickolson; J H Wieringa; A M van Delft
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-04       Impact factor: 3.000

5.  The effect of medetomidine, an alpha 2-adrenoceptor agonist, on plasma atrial natriuretic peptide levels, haemodynamics and renal excretory function in spontaneously hypertensive and Wistar-Kyoto rats.

Authors:  H Ruskoaho; J Leppäluoto
Journal:  Br J Pharmacol       Date:  1989-05       Impact factor: 8.739

6.  Facilitatory influence of noradrenergic afferents on the excitability of rat paraventricular nucleus neurosecretory cells.

Authors:  T A Day; A V Ferguson; L P Renaud
Journal:  J Physiol       Date:  1984-10       Impact factor: 5.182

Review 7.  A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice.

Authors:  Melissa D Sinclair
Journal:  Can Vet J       Date:  2003-11       Impact factor: 1.008

8.  Cardiovascular effects of alpha-adrenergic drugs: differences between clonidine and guanabenz.

Authors:  J S Gutkind; M Kazanietz; M A Enero
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-04       Impact factor: 3.000

9.  Ascending noradrenergic projections from the brainstem: evidence for a major role in the regulation of blood pressure and vasopressin secretion.

Authors:  S L Lightman; K Todd; B J Everitt
Journal:  Exp Brain Res       Date:  1984       Impact factor: 1.972

10.  Antagonistic effects of atipamezole and yohimbine on medetomidine-induced diuresis in healthy dogs.

Authors:  Md Hasanuzzaman Talukder; Yoshiaki Hikasa; Hajime Takahashi; Kanako Sato; Aya Matsuu
Journal:  Can J Vet Res       Date:  2009-10       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.